Namiki Izumi

机构：Musashino Red Cross Hospital · ORCID：0000-0002-0055-8229

发表论文 649 篇 · 总被引 30538 次 · h-index 81

代表论文

• Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease (2024 · Alimentary Pharmacology & Therapeutics · 被引 30)
• Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues (2024 · Cell Genomics · 被引 25)
• Blood DNA virome associates with autoimmune diseases and COVID-19 (2025 · Nature Genetics · 被引 21)
• Colorectal Cancer Incidence in Steatotic Liver Disease (MASLD, MetALD, and ALD) (2025 · Clinical Gastroenterology and Hepatology · 被引 20)
• Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study (2025 · Journal of Gastroenterology · 被引 12)
• Deciphering state-dependent immune features from multi-layer omics data at single-cell resolution (2025 · Nature Genetics · 被引 10)